MedPath

How effective is the Repetitive Transcranial Magnetic Stimulation (rTMS) in improving Daily Living, Behaviour and Cognitive ability of Parkinson disease Patients: A Randomized Controlled Trial

Recruiting
Conditions
Parkinsons disease,
Registration Number
CTRI/2019/11/021847
Lead Sponsor
Department of Biotechnology
Brief Summary

Parkinsons Disease (PD) is the second most common neurodegenerative disorder and the most common movement disorder. The present research aims to study the efficacy of the Rtms using a neural navigator. This makes the work and therapeutic efficacy free from human error. Hence, if our research turns out to be positive at the completion of this project, then this program can be used for providing rTMS to patients suffering from Parkinson Disease along with other movement related disorders in order to improve their quality of life domains including cognition and behavioural aspect as they are found to be impaired which often gets under diagnosed and is found to have disabling effects on their lives. Hence, such treatment would help them restore optimal functional independence, moreover. It would also help in clinical and public health perspective. Since the existing management method (pharmacological) for various neurological disorders more often aims at relieving physical symptoms than neuropsychological symptoms. Hence such a study was planned where the quality of life is targeted for better community and social integration.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Consenting Individual 2.
  • Patients diagnosed with idopathic Parkinson disease (As per UK Brain Bank Criteria) 3.
  • Ability to sustain rTMS procedure for 2 weeks time period.
  • All education levels 4.
  • Urban and rural 5.
  • Right/left handedness.
Exclusion Criteria

•Those not consenting •Any history of major psychiatric illness •Acute head injury •Patients with severe Depression on BDI-II (≥29).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cognition and Behavioural domains of Parkinson disease Patients.baseline | 1 month | 3 months | 6 months
Secondary Outcome Measures
NameTimeMethod
Parkinson Disease- Quality of Life- 39Parkinson Disease- Quality of Life- 39

Trial Locations

Locations (1)

All India Institute of Medical Sciences, New Delhi

🇮🇳

Delhi, DELHI, India

All India Institute of Medical Sciences, New Delhi
🇮🇳Delhi, DELHI, India
Dr Ashima Nehra
Principal investigator
9810882765
ashimanwadhawan@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.